Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000150062 | SCV000112662 | benign | not specified | 2018-02-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000150062 | SCV000168139 | benign | not specified | 2014-04-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000150062 | SCV000268969 | benign | not specified | 2015-01-13 | criteria provided, single submitter | clinical testing | c.7542+13A>G in intron 51 of DMD: This variant is not expected to have clinical significance because it is not located within the conserved splice consensus seq uence. It has been identified in 0.8% (51/6728) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.wa shington.edu/EVS; dbSNP rs72466585). |
Prevention |
RCV000150062 | SCV000309942 | benign | not specified | criteria provided, single submitter | clinical testing | ||
ARUP Laboratories, |
RCV001529274 | SCV001159453 | benign | not provided | 2020-07-10 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001169692 | SCV001332452 | likely benign | Dilated cardiomyopathy 3B | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000150062 | SCV001338963 | benign | not specified | 2020-03-12 | criteria provided, single submitter | clinical testing | Variant summary: DMD c.7542+13A>G alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0038 in 181738 control chromosomes in the gnomAD database, including 1 homozygote and 271 hemizygotes. The observed variant frequency is at least 348-fold of the estimated maximal expected allele frequency for a pathogenic variant in DMD causing Dystrophinopathies phenotype, strongly suggesting that the variant is benign. Three ClinVar submitters (evaluation after 2014) cite the variant as benign. Based on the evidence outlined above, the variant was classified as benign. |
Labcorp Genetics |
RCV001511001 | SCV001718174 | benign | Duchenne muscular dystrophy | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002483143 | SCV002800290 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Dilated cardiomyopathy 3B | 2021-07-27 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001529274 | SCV005209177 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV001529274 | SCV001742444 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000150062 | SCV001932181 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000150062 | SCV002035893 | benign | not specified | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001831871 | SCV002087756 | benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2018-04-11 | no assertion criteria provided | clinical testing |